{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T03:18:22Z","timestamp":1649128702470},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.encep.2015.05.004","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T01:13:19Z","timestamp":1452647599000},"page":"124-129","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescription et surveillance d\u2019antipsychotiques chez les patients \u00e2g\u00e9s souffrant de schizophr\u00e9nie\u00a0: pratiques des psychiatres et leurs d\u00e9terminants"],"prefix":"10.1016","volume":"42","author":[{"given":"I.","family":"Jalenques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Auclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2015.05.004_bib0135","first-page":"345","article-title":"Old patients suffering from long-standing schizophrenia: clinical aspects","volume":"9","author":"Jalenques","year":"2011","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"10.1016\/j.encep.2015.05.004_bib0140","first-page":"CD005580","article-title":"Antipsychotic medication for elderly people with schizophrenia","author":"Marriott","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl. 2","key":"10.1016\/j.encep.2015.05.004_bib0145","first-page":"5","article-title":"Using antipsychotic agents in older patients","volume":"65","author":"Alexopoulos","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0150","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/15622970500483177","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 2: long-term treatment of schizophrenia","volume":"7","author":"Falkai","year":"2006","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0160","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia. Part 1: acute treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World J Biol Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1192\/bjp.182.3.241","article-title":"Care needs of elderly people with schizophrenia. Assessment of an epidemiologically defined cohort in Scotland","volume":"182","author":"McNulty","year":"2003","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0170","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1176\/ps.2008.59.8.853","article-title":"Adequacy of medical treatment among older persons with schizophrenia","volume":"59","author":"Vahia","year":"2008","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.encep.2015.05.004_bib0175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1017\/S1041610211001487","article-title":"Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France","volume":"24","author":"Arbus","year":"2012","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.encep.2015.05.004_bib0180","series-title":"Atlas de la d\u00e9mographie m\u00e9dicale en France\u00a0: situation au 1er janvier 2009","author":"Conseil National de l\u2019Ordre des M\u00e9decins","year":"2009"},{"key":"10.1016\/j.encep.2015.05.004_bib0185","first-page":"35","article-title":"Are postal questionnaire surveys of reported activity valid? An exploration using general practitioner management of hypertension in older people","volume":"49","author":"Eccles","year":"1999","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.encep.2015.05.004_bib0190","first-page":"181","article-title":"Statistiques en psychiatrie en France\u00a0: donn\u00e9es de cadrage","volume":"1","author":"Cases","year":"2004","journal-title":"Rev Fr Affaires Soc"},{"key":"10.1016\/j.encep.2015.05.004_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0013-7006(13)70121-0","article-title":"French Society for Biological Psychiatry and Neuropsychopharmacology task force: formal consensus for the prescription of depot antipsychotics","volume":"39","author":"Samalin","year":"2014","journal-title":"Enc\u00e9phale"},{"issue":"Suppl. 1","key":"10.1016\/j.encep.2015.05.004_bib0200","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.encep.2012.03.005","article-title":"Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists","volume":"39","author":"Misdrahi","year":"2013","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2015.05.004_bib0205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.encep.2014.12.003","article-title":"Vigilance level for cardiovascular risk factors in schizophrenic patients","volume":"41","author":"Rouillon","year":"2015","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2015.05.004_bib0210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archgenpsychiatry.2009.61","article-title":"Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder","volume":"66","author":"Laursen","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0215","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.encep.2008.10.014","article-title":"Drawing up guidelines for the attendance of physical health of patients with severe mental illness","volume":"35","author":"Saravane","year":"2009","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2015.05.004_bib0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","article-title":"Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia","volume":"21","author":"Barnett","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.encep.2015.05.004_bib0225","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/ATVBAHA.107.159228","article-title":"Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk","volume":"28","author":"Despres","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.encep.2015.05.004_bib0230","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-244X-7-28","article-title":"A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients","volume":"7","author":"Mackin","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0235","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1176\/appi.psy.43.5.354","article-title":"Cataract occurrence with antipsychotic drugs","volume":"43","author":"Shahzad","year":"2002","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2015.05.004_bib0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/070674370505000909","article-title":"Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring","volume":"50","author":"Poulin","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2015.05.004_bib0245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.encep.2012.03.002","article-title":"Antipsychotic drug-induced hyperprolactinemia: physiopathology, clinical features and guidance","volume":"40","author":"Besnard","year":"2014","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2015.05.004_bib0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0269881107087346","article-title":"Antipsychotics and hyperprolactinaemia: clinical recommendations","volume":"22","author":"Peveler","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.encep.2015.05.004_bib0255","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/ps.2008.59.5.561","article-title":"Psychiatric opinion and antipsychotic selection in the management of schizophrenia","volume":"59","author":"Arbuckle","year":"2008","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.encep.2015.05.004_bib0130","first-page":"278","article-title":"Atypical antipsychotics management in old people with schizophrenia","volume":"170","author":"Legrand","year":"2012","journal-title":"Ann Med Psychol"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700615002225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700615002225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T02:53:43Z","timestamp":1537066423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700615002225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0013700615002225"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2015.05.004","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prescription et surveillance d\u2019antipsychotiques chez les patients \u00e2g\u00e9s souffrant de schizophr\u00e9nie\u00a0: pratiques des psychiatres et leurs d\u00e9terminants","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2015.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}